£100
No changevs May 2025Active15712708Private limited companyLondon
EXE BIOTECH LTD
Significant control: Mark William Chapman Spencer (25–50%), Barbara Bos (significant control)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Coming soon · product and service lists
What does Exe Biotech Ltd sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
EXE BIOTECH LTD is an active private limited company (company number 15712708) incorporated on 10 May 2024, registered in London. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest dormant accounts cover the period ending 31 May 2026, showing net assets of £100. Net assets were unchanged on the prior period.
Peer position · net assets
By net assets it sits in the lower half of 603 comparable companies in London (median £440, upper quartile £92k).
02
Ownership and control
- Mr Mark William Chapman Spencer
- owns 25–50% of shares
- holds 25–50% of voting rights
- Ms Barbara Bos
- has significant influence or control
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 10 May 20242 yrs ago
- Next accounts due
- 29 February 2028in 494 days
- Confirmation statement due
- 24 May 2027in 213 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- SIC 72190
- Other research and experimental development on natural sciences and engineering
- Accounts type
- Dormant
- Size band
- MicroCompanies Act thresholds
05
Financials
Not reported
Not reported
Not reported
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 May 2026 | £100 | — | — | — | — | — | — |
| 31 May 2025 | £100 | — | — | — | — | — | — |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets above zeroNet assets £100 at 31 May 2026
- Incorporated two to five years agoIncorporated 10 May 2024
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Next accounts duein 494 days
- Confirmation statement duein 213 days
- Accounts period endNet assets £100 · dormant accounts
- Accounts period endNet assets £100 · dormant accounts
- Incorporated
08
Similar companies in London
- NANOGEIOS LABORATORY LTDLondon · inc. May 2024
- QUALITEC FARMA LTDLondon · inc. May 2024
- SENTINAL4D LIMITEDLondon · inc. May 2024
- IONA THERAPEUTICS LIMITEDLondon · inc. May 2024
- AITEKIT LTDLondon · inc. May 2024
- ATHERNAL BIO LIMITEDLondon · inc. May 2024
All companies incorporated on 10 May 2024 · in May 2024.
09
Reminders for EXE BIOTECH LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.